Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to anti-arrhythmic drugs in patients with persistent AFib, a spokesperson said.

After Alabama's 24-17 loss to Tennessee, fans rushed the field and tore down both goalposts, reminiscent of what was done after the Volunteers' 52-49 win against Alabama in 2022. And once again ...

Rates of survival after out-of-hospital cardiac arrest (OHCA) have not fully bounced back since the COVID-19 pandemic, ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Two years after the tunnel fight, Michigan football and Michigan State football ended their latest rivalry game with a fight on the field after Michigan quarterback Davis Warren took a knee to ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

With that, we look at the 10 Best Low Volatility Stocks to Invest in Now.

The device, Varipulse, is a pulsed field ablation system which uses small burns or freezes to cause some scarring in the ...